Close Menu

BERLIN (GenomeWeb) – Qiagen has been marketing its GeneReader next-generation sequencing system as a complete solution — with an automated sample prep, assay, and informatics workflow that includes instrumentation, reagents, and software for analysis and clinical reporting — to molecular pathology and diagnostics laboratories, initially for oncology applications.

At the Association for Molecular Pathology's AMP Global Congress in Berlin this week, several customers and users of the GeneReader presented results from initial studies conducted on the platform.

Get the full story with
360Dx Premium

Only $95 for the
first 90 days*

360Dx Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try 360Dx Premium now.

You may already have institutional access!

Check if I qualify.

Already a 360Dx or GenomeWeb Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.